Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Die Operneinakter 'La Lotta d'Hercole con Acheloo' und 'Baccanali' von Agostino Steffani : Mit einer Einführung zur Form des Operneinakters im zeitgenössischen Kontext und einer historisch-kritischen Edition von 'Baccanali'

Autor: Waltraut Anna Lach

Der italienische Komponist Agostino Steffani (1654–1728) erlebt in den letzten Jahren sowohl in der Musikwissenschaft als auch in der Aufführungspraxis eine Renaissance. Das zunehmende Forschungsinteresse erstreckte sich jedoch bislang kaum auf se

Vorwort

Autor: Waltraut Anna Lach

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::39883db7be873c08d8db5e36524ae2e4
https://doi.org/10.2307/j.ctvwh8cn9.3

RNA-seq of newly diagnosed patients in the PADIMAC study leads to a bortezomib/lenalidomide decision signature

Autor: Rakesh Popat, Laura Clifton-Hadley, Mahnaz Abbasian, Pieter Sonneveld, John Ambrose, Heather Oakervee, Matthew Streetly, Stephen Schey, Michael A Chapman, Jonathan J Keats, Fenella Willis, Kwee Yong, Charles Crawley, Paul Smith, Anna Lach, Michael F. Quinn, Jamie Cavenagh, Josephine Crowe, Mickey Koh, Nivette Braganza, Javier Herrero, Nicholas Counsell, Toyin Adedayo, Guy Pratt, Andres Virchis, Jonathan Sive, Mark Cook, Gordon Cook, Roger G. Owen, Claire Roddie

Publikováno v: Blood, 132(20), 2154-2165. American Society of Hematology

Improving outcomes in multiple myeloma will involve not only development of new therapies but also better use of existing treatments. We performed RNA sequencing on samples from newly diagnosed patients enrolled in the phase 2 PADIMAC (Bortezomib, Ad

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8556896472fa246e1d0816c6d45cb76c
https://pubmed.ncbi.nlm.nih.gov/30442746

Ammonium tetrathiomolybdate following ischemia/reperfusion injury: Chemistry, pharmacology, and impact of a new class of sulfide donor in preclinical injury models

Autor: Iain P. Hargreaves, Felipe Dal-Pizzol, Martin Feelisch, Anna Lach, Federica Galfo, Bernardo Bollen Pinto, Daniel I. Bromage, John Martin, Giovanni Sabbatini, Kevin Moore, Juliano Dos Santos Cardoso, Mervyn Singer, Bruna P. Mendonça, Alex Dyson

Publikováno v: PLoS Medicine
PLoS Medicine, Vol 14, Iss 7, p e1002310 (2017)
Dyson, A, Dal-Pizzol, F, Sabbatini, G, Lach, A, dos Santos Cardoso, J, Pescador Mendonca, B, Hargreaves, I, Bollen Pinto, B, Bromage, D, Martin, J, Moore, K, Feelisch, M & Singer, M 2017, ' Ammonium tetrathiomolybdate following ischemia/reperfusion injury: Chemistry, pharmacology, and impact of a new class of sulfide donor in preclinical injury models ', PLoS Medicine, vol. 14, no. 7, e1002310 . https://doi.org/10.1371/journal.pmed.1002310
PLOS Medicine, Vol. 14, No 7 (2017) P. e1002310

Background Early revascularization of ischemic organs is key to improving outcomes, yet consequent reperfusion injury may be harmful. Reperfusion injury is largely attributed to excess mitochondrial production of reactive oxygen species (ROS). Sulfid

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::454c7cff6de7aecdfe0a4b61e8956011
https://pubmed.ncbi.nlm.nih.gov/28678794